Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Robert W. Krell

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4800-3123; OpenAlex author ID A5102764996. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2021: 3 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 8

  1. Localized Pancreatic Cancer among Military Beneficiaries: A National Cancer Database Analysis. Co-author DOI 10.1093/milmed/usaf465↗
  2. Pancreatic cancer: a haystack of needles. First author DOI 10.21037/jgo-24-697↗
  3. Morbidity and Mortality of Non-pancreatectomy operations for pancreatic cancer: An ACS-NSQIP analysis. Last author DOI 10.1016/j.amjsurg.2022.08.012↗
  4. Geographic variation in attitudes regarding management of locally advanced pancreatic cancer. Co-author DOI 10.1016/j.sopen.2022.07.007↗
  5. Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves Survival. Co-author DOI 10.1245/s10434-022-11800-0↗
  6. Management of Locally Advanced Pancreatic Cancer: Results of an International Survey of Current Practice. Co-author DOI 10.1097/sla.0000000000003568↗
  7. Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Propensity-Matched Analysis of Postoperative Complications Using ACS-NSQIP. Co-author DOI 10.1245/s10434-020-09460-z↗
  8. Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2147/ott.s311661↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bradley Norman Reames · 4 shared papers, 2021–2023 · strength 0.73
  2. Alexandra M. Adams · 3 shared papers, 2021–2023 · strength 0.57
  3. Nicholas L Michael · 1 shared paper, 2024 · strength 0.46
  4. Robert Connor Chick · 2 shared papers, 2022–2026 · strength 0.44
  5. Elizabeth L. Carpenter · 2 shared papers, 2022–2026 · strength 0.44
  6. Chandrakanth Are · 3 shared papers, 2021–2022 · strength 0.43
  7. Logan R. McNeil · 2 shared papers, 2021–2022 · strength 0.31
  8. Joal D. Beane · 1 shared paper, 2026 · strength 0.30
  9. Patrick W. Underwood · 1 shared paper, 2026 · strength 0.30
  10. Jordan M. Cloyd · 1 shared paper, 2026 · strength 0.30
  11. Timothy Michael Pawlik · 1 shared paper, 2026 · strength 0.30
  12. Patrick M. McCarthy · 2 shared papers, 2021–2022 · strength 0.26
  13. Anne E. O’Shea · 2 shared papers, 2021–2022 · strength 0.26
  14. Daniel William Nelson · 2 shared papers, 2021–2022 · strength 0.26
  15. Timothy J. Vreeland · 2 shared papers, 2021–2022 · strength 0.26
  16. Jin Peng He · 2 shared papers, 2021–2022 · strength 0.25
  17. Georgios Gemenetzis · 2 shared papers, 2021–2022 · strength 0.25
  18. Christopher Lee Wolfgang · 2 shared papers, 2021–2022 · strength 0.25
  19. Matthew John Weiss · 2 shared papers, 2021–2022 · strength 0.25
  20. Massimo Falconi · 2 shared papers, 2021–2022 · strength 0.25
  21. Vincent P. Groot · 2 shared papers, 2021–2022 · strength 0.25
  22. Alex B. Blair · 2 shared papers, 2021–2022 · strength 0.25
  23. Phillip M. Kemp Bohan · 1 shared paper, 2022 · strength 0.14
  24. Chunmeng Zhang · 1 shared paper, 2022 · strength 0.13
  25. Aslam M. Ejaz · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.